table of content
1 Introduction to Research & Analysis Reports
1.1 Oncology Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology Drugs Overall Market Size
2.1 Global Oncology Drugs Market Size: 2022 VS 2029
2.2 Global Oncology Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncology Drugs Players in Global Market
3.2 Top Global Oncology Drugs Companies Ranked by Revenue
3.3 Global Oncology Drugs Revenue by Companies
3.4 Top 3 and Top 5 Oncology Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oncology Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncology Drugs Players in Global Market
3.6.1 List of Global Tier 1 Oncology Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncology Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oncology Drugs Market Size Markets, 2022 & 2029
4.1.2 Chemotherapy
4.1.3 Targeted Therapy
4.1.4 Immunotherapy (Biologic Therapy)
4.1.5 Hormonal Therapy
4.1.6 Others
4.2 By Type - Global Oncology Drugs Revenue & Forecasts
4.2.1 By Type - Global Oncology Drugs Revenue, 2018-2023
4.2.2 By Type - Global Oncology Drugs Revenue, 2024-2029
4.2.3 By Type - Global Oncology Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncology Drugs Market Size, 2022 & 2029
5.1.2 Blood Cancer
5.1.3 Breast Cancer
5.1.4 Gastrointestinal Cancer
5.1.5 Prostate Cancer
5.1.6 Respiratory or Lung Cancer
5.1.7 Others
5.2 By Application - Global Oncology Drugs Revenue & Forecasts
5.2.1 By Application - Global Oncology Drugs Revenue, 2018-2023
5.2.2 By Application - Global Oncology Drugs Revenue, 2024-2029
5.2.3 By Application - Global Oncology Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Oncology Drugs Market Size, 2022 & 2029
6.2 By Region - Global Oncology Drugs Revenue & Forecasts
6.2.1 By Region - Global Oncology Drugs Revenue, 2018-2023
6.2.2 By Region - Global Oncology Drugs Revenue, 2024-2029
6.2.3 By Region - Global Oncology Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Oncology Drugs Revenue, 2018-2029
6.3.2 US Oncology Drugs Market Size, 2018-2029
6.3.3 Canada Oncology Drugs Market Size, 2018-2029
6.3.4 Mexico Oncology Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Oncology Drugs Revenue, 2018-2029
6.4.2 Germany Oncology Drugs Market Size, 2018-2029
6.4.3 France Oncology Drugs Market Size, 2018-2029
6.4.4 U.K. Oncology Drugs Market Size, 2018-2029
6.4.5 Italy Oncology Drugs Market Size, 2018-2029
6.4.6 Russia Oncology Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Oncology Drugs Market Size, 2018-2029
6.4.8 Benelux Oncology Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Oncology Drugs Revenue, 2018-2029
6.5.2 China Oncology Drugs Market Size, 2018-2029
6.5.3 Japan Oncology Drugs Market Size, 2018-2029
6.5.4 South Korea Oncology Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Oncology Drugs Market Size, 2018-2029
6.5.6 India Oncology Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Oncology Drugs Revenue, 2018-2029
6.6.2 Brazil Oncology Drugs Market Size, 2018-2029
6.6.3 Argentina Oncology Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oncology Drugs Revenue, 2018-2029
6.7.2 Turkey Oncology Drugs Market Size, 2018-2029
6.7.3 Israel Oncology Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Oncology Drugs Market Size, 2018-2029
6.7.5 UAE Oncology Drugs Market Size, 2018-2029
7 Oncology Drugs Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Oncology Drugs Major Product Offerings
7.1.4 Roche Oncology Drugs Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Celgene
7.2.1 Celgene Company Summary
7.2.2 Celgene Business Overview
7.2.3 Celgene Oncology Drugs Major Product Offerings
7.2.4 Celgene Oncology Drugs Revenue in Global Market (2018-2023)
7.2.5 Celgene Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Oncology Drugs Major Product Offerings
7.3.4 Novartis Oncology Drugs Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Oncology Drugs Major Product Offerings
7.4.4 Bristol-Myers Squibb Oncology Drugs Revenue in Global Market (2018-2023)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Oncology Drugs Major Product Offerings
7.5.4 Johnson & Johnson Oncology Drugs Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Merck & Co.
7.6.1 Merck & Co. Company Summary
7.6.2 Merck & Co. Business Overview
7.6.3 Merck & Co. Oncology Drugs Major Product Offerings
7.6.4 Merck & Co. Oncology Drugs Revenue in Global Market (2018-2023)
7.6.5 Merck & Co. Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Oncology Drugs Major Product Offerings
7.7.4 AstraZeneca Oncology Drugs Revenue in Global Market (2018-2023)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Oncology Drugs Major Product Offerings
7.8.4 Pfizer Oncology Drugs Revenue in Global Market (2018-2023)
7.8.5 Pfizer Key News & Latest Developments
7.9 Amgen
7.9.1 Amgen Company Summary
7.9.2 Amgen Business Overview
7.9.3 Amgen Oncology Drugs Major Product Offerings
7.9.4 Amgen Oncology Drugs Revenue in Global Market (2018-2023)
7.9.5 Amgen Key News & Latest Developments
7.10 Eli Lilly
7.10.1 Eli Lilly Company Summary
7.10.2 Eli Lilly Business Overview
7.10.3 Eli Lilly Oncology Drugs Major Product Offerings
7.10.4 Eli Lilly Oncology Drugs Revenue in Global Market (2018-2023)
7.10.5 Eli Lilly Key News & Latest Developments
7.11 AbbVie
7.11.1 AbbVie Company Summary
7.11.2 AbbVie Business Overview
7.11.3 AbbVie Oncology Drugs Major Product Offerings
7.11.4 AbbVie Oncology Drugs Revenue in Global Market (2018-2023)
7.11.5 AbbVie Key News & Latest Developments
7.12 Takeda
7.12.1 Takeda Company Summary
7.12.2 Takeda Business Overview
7.12.3 Takeda Oncology Drugs Major Product Offerings
7.12.4 Takeda Oncology Drugs Revenue in Global Market (2018-2023)
7.12.5 Takeda Key News & Latest Developments
7.13 Astellas
7.13.1 Astellas Company Summary
7.13.2 Astellas Business Overview
7.13.3 Astellas Oncology Drugs Major Product Offerings
7.13.4 Astellas Oncology Drugs Revenue in Global Market (2018-2023)
7.13.5 Astellas Key News & Latest Developments
7.14 Ipsen
7.14.1 Ipsen Company Summary
7.14.2 Ipsen Business Overview
7.14.3 Ipsen Oncology Drugs Major Product Offerings
7.14.4 Ipsen Oncology Drugs Revenue in Global Market (2018-2023)
7.14.5 Ipsen Key News & Latest Developments
7.15 Sanofi
7.15.1 Sanofi Company Summary
7.15.2 Sanofi Business Overview
7.15.3 Sanofi Oncology Drugs Major Product Offerings
7.15.4 Sanofi Oncology Drugs Revenue in Global Market (2018-2023)
7.15.5 Sanofi Key News & Latest Developments
7.16 Bayer
7.16.1 Bayer Company Summary
7.16.2 Bayer Business Overview
7.16.3 Bayer Oncology Drugs Major Product Offerings
7.16.4 Bayer Oncology Drugs Revenue in Global Market (2018-2023)
7.16.5 Bayer Key News & Latest Developments
7.17 Biogen Idec
7.17.1 Biogen Idec Company Summary
7.17.2 Biogen Idec Business Overview
7.17.3 Biogen Idec Oncology Drugs Major Product Offerings
7.17.4 Biogen Idec Oncology Drugs Revenue in Global Market (2018-2023)
7.17.5 Biogen Idec Key News & Latest Developments
7.18 Teva
7.18.1 Teva Company Summary
7.18.2 Teva Business Overview
7.18.3 Teva Oncology Drugs Major Product Offerings
7.18.4 Teva Oncology Drugs Revenue in Global Market (2018-2023)
7.18.5 Teva Key News & Latest Developments
7.19 Otsuka
7.19.1 Otsuka Company Summary
7.19.2 Otsuka Business Overview
7.19.3 Otsuka Oncology Drugs Major Product Offerings
7.19.4 Otsuka Oncology Drugs Revenue in Global Market (2018-2023)
7.19.5 Otsuka Key News & Latest Developments
7.20 Eisai
7.20.1 Eisai Company Summary
7.20.2 Eisai Business Overview
7.20.3 Eisai Oncology Drugs Major Product Offerings
7.20.4 Eisai Oncology Drugs Revenue in Global Market (2018-2023)
7.20.5 Eisai Key News & Latest Developments
7.21 Merck KGaA
7.21.1 Merck KGaA Company Summary
7.21.2 Merck KGaA Business Overview
7.21.3 Merck KGaA Oncology Drugs Major Product Offerings
7.21.4 Merck KGaA Oncology Drugs Revenue in Global Market (2018-2023)
7.21.5 Merck KGaA Key News & Latest Developments
7.22 Gilead Sciences
7.22.1 Gilead Sciences Company Summary
7.22.2 Gilead Sciences Business Overview
7.22.3 Gilead Sciences Oncology Drugs Major Product Offerings
7.22.4 Gilead Sciences Oncology Drugs Revenue in Global Market (2018-2023)
7.22.5 Gilead Sciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
